Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

MS-MLPA can be used for classification of certain types of lung tumors and clinical outcome prediction. This latter is clinically relevant by offering an adjunct strategy for the clinical management of lung cancer patients.